Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients

NCT04022616 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 99

Last updated 2026-04-06

No results posted yet for this study

Summary

Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients

Conditions

Interventions

OTHER

Specimen collection

Specimens are obtained from patients who are being treated for breast malignancies.

Sponsors & Collaborators

  • Ohio State University Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • William Carson, MD · Ohio State Comprehensive Cancer Center

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-04
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04022616 on ClinicalTrials.gov